AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) EBITDA

Annual EBITDA:

$33.52M+$105.18M(+146.77%)
December 31, 2024

Summary

  • As of today, AUPH annual EBITDA is $33.52 million, with the most recent change of +$105.18 million (+146.77%) on December 31, 2024.
  • During the last 3 years, AUPH annual EBITDA has risen by +$210.92 million (+118.89%).
  • AUPH annual EBITDA is now at all-time high.

Performance

AUPH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

Quarterly EBITDA:

$35.54M+$1.23M(+3.59%)
September 30, 2025

Summary

  • As of today, AUPH quarterly EBITDA is $35.54 million, with the most recent change of +$1.23 million (+3.59%) on September 30, 2025.
  • Over the past year, AUPH quarterly EBITDA has increased by +$14.32 million (+67.52%).
  • AUPH quarterly EBITDA is now at all-time high.

Performance

AUPH Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

TTM EBITDA:

$116.55M+$14.32M(+14.01%)
September 30, 2025

Summary

  • As of today, AUPH TTM EBITDA is $116.55 million, with the most recent change of +$14.32 million (+14.01%) on September 30, 2025.
  • Over the past year, AUPH TTM EBITDA has increased by +$112.72 million (+2944.64%).
  • AUPH TTM EBITDA is now at all-time high.

Performance

AUPH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

AUPH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+146.8%+67.5%+2944.6%
3Y3 Years+118.9%+494.8%+203.7%
5Y5 Years+144.8%+182.8%+201.6%

AUPH EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+118.9%at high+218.3%at high+203.7%
5Y5-Yearat high+118.9%at high+171.7%at high+165.7%
All-TimeAll-Timeat high+118.9%at high+171.7%at high+165.7%

AUPH EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$35.54M(+3.6%)
$116.55M(+14.0%)
Jun 2025
-
$34.31M(+5.0%)
$102.22M(+41.9%)
Mar 2025
-
$32.66M(+132.7%)
$72.03M(+114.9%)
Dec 2024
$33.52M(+146.8%)
$14.04M(-33.8%)
$33.52M(+775.6%)
Sep 2024
-
$21.21M(+415.9%)
$3.83M(+115.0%)
Jun 2024
-
$4.11M(+170.3%)
-$25.55M(+47.6%)
Mar 2024
-
-$5.85M(+62.6%)
-$48.74M(+31.8%)
Dec 2023
-$71.67M(+35.0%)
-$15.65M(-91.7%)
-$71.47M(+16.8%)
Sep 2023
-
-$8.16M(+57.2%)
-$85.87M(+1.0%)
Jun 2023
-
-$19.08M(+33.2%)
-$86.71M(+15.9%)
Mar 2023
-
-$28.58M(+4.9%)
-$103.10M(+6.4%)
Dec 2022
-$110.29M(+37.8%)
-$30.05M(-233.9%)
-$110.14M(+2.0%)
Sep 2022
-
-$9.00M(+74.6%)
-$112.39M(+26.5%)
Jun 2022
-
-$35.47M(+0.4%)
-$152.97M(+7.2%)
Mar 2022
-
-$35.61M(-10.2%)
-$164.86M(+7.0%)
Dec 2021
-$177.40M(-84.6%)
-$32.30M(+34.9%)
-$177.33M(-20.7%)
Sep 2021
-
-$49.58M(-4.7%)
-$146.93M(-4.8%)
Jun 2021
-
-$47.37M(+1.5%)
-$140.26M(-17.5%)
Mar 2021
-
-$48.08M(-2432.1%)
-$119.39M(-24.2%)
Dec 2020
-$96.11M(-28.4%)
-$1.90M(+95.6%)
-$96.16M(+16.2%)
Sep 2020
-
-$42.92M(-62.0%)
-$114.77M(-20.2%)
Jun 2020
-
-$26.50M(-6.6%)
-$95.47M(-12.3%)
Mar 2020
-
-$24.85M(-21.1%)
-$85.05M(-13.8%)
Dec 2019
-$74.85M(-37.1%)
-$20.51M(+13.2%)
-$74.70M(-9.1%)
Sep 2019
-
-$23.62M(-47.0%)
-$68.50M(-16.9%)
Jun 2019
-
-$16.07M(-10.8%)
-$58.58M(-3.8%)
Mar 2019
-
-$14.50M(-1.4%)
-$56.45M(-3.4%)
Dec 2018
-$54.59M(-19.7%)
-$14.31M(-4.4%)
-$54.59M(-4.9%)
Sep 2018
-
-$13.70M(+1.7%)
-$52.06M(-0.5%)
Jun 2018
-
-$13.94M(-10.2%)
-$51.79M(-9.0%)
Mar 2018
-
-$12.65M(-7.4%)
-$47.53M(-4.2%)
Dec 2017
-$45.61M(-113.8%)
-$11.78M(+12.3%)
-$45.61M(-9.9%)
Sep 2017
-
-$13.43M(-38.7%)
-$41.49M(-25.4%)
Jun 2017
-
-$9.68M(+9.7%)
-$33.09M(-19.9%)
Mar 2017
-
-$10.72M(-40.0%)
-$27.60M(-29.4%)
Dec 2016
-$21.34M(+3.1%)
-$7.66M(-52.3%)
-$21.34M(-13.3%)
Sep 2016
-
-$5.03M(-20.1%)
-$18.84M(+4.9%)
Jun 2016
-
-$4.19M(+6.1%)
-$19.80M(+7.1%)
Mar 2016
-
-$4.46M(+13.6%)
-$21.30M(+3.3%)
Dec 2015
-$22.02M(-37.6%)
-$5.16M(+13.9%)
-$22.02M(-3.1%)
Sep 2015
-
-$5.99M(-5.4%)
-$21.35M(-11.6%)
Jun 2015
-
-$5.69M(-9.9%)
-$19.13M(-8.4%)
Mar 2015
-
-$5.18M(-15.3%)
-$17.64M(-10.1%)
Dec 2014
-$16.00M(-356.4%)
-$4.49M(-18.9%)
-$16.02M(-27.1%)
Sep 2014
-
-$3.78M(+10.1%)
-$12.61M(-29.1%)
Jun 2014
-
-$4.20M(-18.0%)
-$9.77M(-52.2%)
Mar 2014
-
-$3.56M(-230.0%)
-$6.42M(-78.2%)
Dec 2013
-$3.51M(+26.8%)
-$1.08M(-15.7%)
-$3.60M(+52.3%)
Sep 2013
-
-$932.00K(-9.9%)
-$7.55M(+7.7%)
Jun 2013
-
-$848.00K(-14.3%)
-$8.19M(+14.2%)
Mar 2013
-
-$742.00K(+85.2%)
-$9.54M(-93.5%)
Dec 2012
-$4.79M
-$5.03M(-221.3%)
-$4.93M(-335.3%)
DateAnnualQuarterlyTTM
Sep 2012
-
-$1.57M(+28.9%)
-$1.13M(-128.9%)
Jun 2012
-
-$2.20M(-157.0%)
-$494.90K(-1030.3%)
Mar 2012
-
$3.87M(+414.0%)
$53.20K(+101.0%)
Dec 2011
-$5.72M(-50.8%)
-$1.23M(-32.8%)
-$5.11M(+9.8%)
Sep 2011
-
-$928.00K(+43.9%)
-$5.66M(+4.0%)
Jun 2011
-
-$1.66M(-28.4%)
-$5.90M(-32.6%)
Mar 2011
-
-$1.29M(+27.9%)
-$4.45M(-23.8%)
Dec 2010
-$3.79M(+47.9%)
-$1.79M(-53.6%)
-$3.59M(-16.3%)
Sep 2010
-
-$1.16M(-467.3%)
-$3.09M(+3.6%)
Jun 2010
-
-$205.20K(+52.8%)
-$3.20M(+36.7%)
Mar 2010
-
-$434.60K(+66.2%)
-$5.06M(+27.2%)
Dec 2009
-$7.27M(+55.2%)
-$1.28M(-0.4%)
-$6.95M(+20.5%)
Sep 2009
-
-$1.28M(+38.0%)
-$8.74M(+18.0%)
Jun 2009
-
-$2.06M(+11.3%)
-$10.66M(+22.8%)
Mar 2009
-
-$2.33M(+24.3%)
-$13.81M(+16.0%)
Dec 2008
-$16.22M(+48.5%)
-$3.07M(+3.8%)
-$16.45M(+25.0%)
Sep 2008
-
-$3.20M(+38.7%)
-$21.94M(+15.9%)
Jun 2008
-
-$5.22M(-5.2%)
-$26.10M(+12.9%)
Mar 2008
-
-$4.96M(+42.1%)
-$29.97M(+5.2%)
Dec 2007
-$31.48M(-37.5%)
-$8.57M(-16.4%)
-$31.60M(-6.7%)
Sep 2007
-
-$7.36M(+19.0%)
-$29.63M(-4.4%)
Jun 2007
-
-$9.08M(-37.7%)
-$28.37M(-13.7%)
Mar 2007
-
-$6.60M(-0.0%)
-$24.96M(-8.9%)
Dec 2006
-$22.89M(+14.9%)
-$6.59M(-8.1%)
-$22.92M(+2.7%)
Sep 2006
-
-$6.10M(-7.5%)
-$23.56M(+1.5%)
Jun 2006
-
-$5.67M(-24.4%)
-$23.92M(+2.9%)
Mar 2006
-
-$4.56M(+36.9%)
-$24.63M(+8.5%)
Dec 2005
-$26.89M(-44.8%)
-$7.23M(-11.9%)
-$26.91M(-1.6%)
Sep 2005
-
-$6.46M(-1.2%)
-$26.49M(-2.0%)
Jun 2005
-
-$6.38M(+6.7%)
-$25.96M(-13.8%)
Mar 2005
-
-$6.84M(-0.5%)
-$22.82M(-20.2%)
Dec 2004
-$18.56M(-104.7%)
-$6.81M(-14.7%)
-$18.99M(-14.0%)
Sep 2004
-
-$5.93M(-83.1%)
-$16.66M(-15.1%)
Jun 2004
-
-$3.24M(-7.7%)
-$14.47M(-56.4%)
Mar 2004
-
-$3.01M(+32.7%)
-$9.25M(-1.2%)
Dec 2003
-$9.07M(-975.7%)
-$4.47M(-19.5%)
-$9.15M(-22.5%)
Sep 2003
-
-$3.74M(-289.6%)
-$7.47M(-305.3%)
Jun 2003
-
$1.97M(+168.0%)
-$1.84M(-30.6%)
Mar 2003
-
-$2.90M(-3.9%)
-$1.41M(-81.3%)
Dec 2002
-$843.20K(+89.9%)
-$2.79M(-248.6%)
-$778.10K(-138.6%)
Sep 2002
-
$1.88M(-21.8%)
$2.02M(+204.1%)
Jun 2002
-
$2.41M(+206.0%)
-$1.94M(+73.7%)
Mar 2002
-
-$2.27M(-9.5%)
-$7.38M(-2.4%)
Dec 2001
-$8.31M(-38.3%)
-
-
Sep 2001
-
-$2.07M(+31.7%)
-$7.20M(-40.4%)
Jun 2001
-
-$3.03M(-44.8%)
-$5.13M(-144.8%)
Mar 2001
-
-$2.10M(-3097.6%)
-$2.10M(-334.8%)
Dec 2000
-$6.01M(-240.6%)
-
-
Nov 1999
-$1.76M(+18.5%)
$69.90K(+120.1%)
-$481.90K(+12.7%)
Aug 1999
-
-$348.20K(>-9900.0%)
-$551.80K(-171.0%)
May 1999
-
$1500.00(+100.7%)
-$203.60K(+0.7%)
Feb 1999
-
-$205.10K
-$205.10K
Nov 1998
-$2.17M
-
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual EBITDA year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly EBITDA year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM EBITDA year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual EBITDA?

The current annual EBITDA of AUPH is $33.52M

What is the all-time high annual EBITDA for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual EBITDA is $33.52M

What is Aurinia Pharmaceuticals Inc. annual EBITDA year-on-year change?

Over the past year, AUPH annual EBITDA has changed by +$105.18M (+146.77%)

What is Aurinia Pharmaceuticals Inc. quarterly EBITDA?

The current quarterly EBITDA of AUPH is $35.54M

What is the all-time high quarterly EBITDA for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly EBITDA is $35.54M

What is Aurinia Pharmaceuticals Inc. quarterly EBITDA year-on-year change?

Over the past year, AUPH quarterly EBITDA has changed by +$14.32M (+67.52%)

What is Aurinia Pharmaceuticals Inc. TTM EBITDA?

The current TTM EBITDA of AUPH is $116.55M

What is the all-time high TTM EBITDA for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM EBITDA is $116.55M

What is Aurinia Pharmaceuticals Inc. TTM EBITDA year-on-year change?

Over the past year, AUPH TTM EBITDA has changed by +$112.72M (+2944.64%)
On this page